166 related articles for article (PubMed ID: 12589380)
21. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
Cavun S; Göktalay G; Millington WR
J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
[TBL] [Abstract][Full Text] [Related]
22. Changes in dopaminergic neurotransmission do not alter somatic or motivational opiate withdrawal-induced symptoms in rats.
Caillé S; Rodriguez-Arias M; Minarro J; Espejo EF; Cador M; Stinus L
Behav Neurosci; 2003 Oct; 117(5):995-1005. PubMed ID: 14570549
[TBL] [Abstract][Full Text] [Related]
23. A comparison of the effects of clonidine and CNQX infusion into the locus coeruleus and the amygdala on naloxone-precipitated opiate withdrawal in the rat.
Taylor JR; Punch LJ; Elsworth JD
Psychopharmacology (Berl); 1998 Jul; 138(2):133-42. PubMed ID: 9718282
[TBL] [Abstract][Full Text] [Related]
24. The glutamate release inhibitor riluzole attenuates the formation of conditioned place aversion induced by naloxone in rats undergoing a single morphine exposure.
Jin C; Araki H; Kawasaki Y; Nagata M; Suemaru K; Shibata K; Hamamura T; Kawasaki H; Gomita Y
Brain Res; 2006 Jan; 1069(1):120-6. PubMed ID: 16360647
[TBL] [Abstract][Full Text] [Related]
25. Mianserin attenuates naloxone-precipitated withdrawal signs in rats acutely or chronically dependent upon morphine.
Neal BS; Sparber SB
J Pharmacol Exp Ther; 1986 Jan; 236(1):157-65. PubMed ID: 3001281
[TBL] [Abstract][Full Text] [Related]
26. Involvement of the bed nucleus of the stria terminalis activated by the central nucleus of the amygdala in the negative affective component of morphine withdrawal in rats.
Nakagawa T; Yamamoto R; Fujio M; Suzuki Y; Minami M; Satoh M; Kaneko S
Neuroscience; 2005; 134(1):9-19. PubMed ID: 15939543
[TBL] [Abstract][Full Text] [Related]
27. [Involvement of the amygdala on place aversion induced by naloxone in single-dose morphine-treated rats].
Ishida S; Shimosaka R; Kawasaki Y; Jin C; Kitamura Y; Araki H; Sendo T; Gomita Y
Yakugaku Zasshi; 2008 Mar; 128(3):395-403. PubMed ID: 18311059
[TBL] [Abstract][Full Text] [Related]
28. Cannabidiol attenuates the expression of conditioned place aversion induced by naloxone-precipitated morphine withdrawal through the activation of 5-HT1A receptors.
Souza AJ; Guimarães FS; Gomes FV
Behav Brain Res; 2023 Jul; 450():114504. PubMed ID: 37209879
[TBL] [Abstract][Full Text] [Related]
29. Conditioned taste aversion from neostigmine or methyl-naloxonium in the nucleus accumbens.
Taylor KM; Mark GP; Hoebel BG
Physiol Behav; 2011 Jul; 104(1):82-6. PubMed ID: 21549734
[TBL] [Abstract][Full Text] [Related]
30. Conditioned sucrose aversions produced by naloxone-precipitated withdrawal from acutely administered morphine.
McDonald RV; Parker LA; Siegel S
Pharmacol Biochem Behav; 1997 Dec; 58(4):1003-8. PubMed ID: 9408206
[TBL] [Abstract][Full Text] [Related]
31. GHB ameliorates naloxone-induced conditioned place aversion and physical aspects of morphine withdrawal in mice.
Maldonado C; Rodríguez-Arias M; Aguilar MA; Miñarro J
Psychopharmacology (Berl); 2004 Dec; 177(1-2):130-40. PubMed ID: 15179545
[TBL] [Abstract][Full Text] [Related]
32. Antagonism of morphine-induced aversive conditioning by naloxone.
LeBlanc AE; Cappell H
Pharmacol Biochem Behav; 1975; 3(2):185-8. PubMed ID: 1144478
[TBL] [Abstract][Full Text] [Related]
33. Development, extinction and reinstatement of morphine withdrawal-induced conditioned place aversion in rats.
Li Y; Liu X; Chen H; Deng H; Xiang X; Chen H; Hao W
Addict Biol; 2007 Sep; 12(3-4):470-7. PubMed ID: 17678507
[TBL] [Abstract][Full Text] [Related]
34. Effects on spontaneous and cocaine-induced behavior of pharmacological inhibition of noradrenergic and serotonergic systems.
Carey RJ; DePalma G; Shanahan A; Damianopoulos EN; Müller CP; Huston JP
Pharmacol Biochem Behav; 2008 Mar; 89(1):54-63. PubMed ID: 18155756
[TBL] [Abstract][Full Text] [Related]
35. Blocking naloxone-precipitated withdrawal in rats and hamsters.
Schnur P; Espinoza M; Flores R; Ortiz S; Vallejos S; Wainwright M
Pharmacol Biochem Behav; 1992 Dec; 43(4):1093-8. PubMed ID: 1475293
[TBL] [Abstract][Full Text] [Related]
36. Effects of intracerebroventricular clonidine on the hypothalamic noradrenaline and plasma corticosterone levels of opiate naive rats and after naloxone-induced withdrawal.
Gonzalvez ML; Milanés MV; Martinez-Piñero MG; Marín MT; Vargas ML
Brain Res; 1994 Jun; 647(2):199-203. PubMed ID: 7922496
[TBL] [Abstract][Full Text] [Related]
37. Alpha-adrenergic mediation of the tail skin temperature response to naloxone in morphine-dependent rats.
Katovich MJ; Simpkins JW; Barney CC
Brain Res; 1987 Nov; 426(1):55-61. PubMed ID: 2825916
[TBL] [Abstract][Full Text] [Related]
38. Clonidine suppression of noradrenergic hyperactivity during morphine withdrawal by clonidine: biochemical studies in rodents and primates.
Roth RH; Elsworth JD; Redmond DE
J Clin Psychiatry; 1982 Jun; 43(6 Pt 2):42-6. PubMed ID: 6806253
[TBL] [Abstract][Full Text] [Related]
39. Morphine sex-dependently induced place conditioning in adult Wistar rats.
Karami M; Zarrindast MR
Eur J Pharmacol; 2008 Mar; 582(1-3):78-87. PubMed ID: 18191832
[TBL] [Abstract][Full Text] [Related]
40. D-cycloserine facilitates extinction of naloxone-induced conditioned place aversion in morphine-dependent rats.
Myers KM; Carlezon WA
Biol Psychiatry; 2010 Jan; 67(1):85-7. PubMed ID: 19782965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
